Viruses and Cancer by Weiss, RA
Boo Po
253
curious that over 30 pages are allocated to insulinomas and
virtually the same to all the other gastrointestinal and panc-
reatic endocnne tumours.
As I have already hinted, the only major omission that I
can find is the limited reference to the use of octreoscan as a
diagnostic agent, which in Europe has become an essential
part of the modern diagnostic protocol for the investigation
of neuroendocrine cancers. However, this can clearly be
updated in future editions, as I am sure this will reach a
second edition. Furthermore, in a future edition a little more
emphasis could be included on the non-surgical therapies of
these cancers.
Who is going to buy this book? Reference libraries should
consider this a must, and it will certainly be purchased by
oncologists, endocrinologists and surgical oncologists with an
interest in thyroid and endocrine cancers. However, the
general oncologist is probably not going to have this on his
shelf. It is also unfortunate that within the next year there is
going to be a rival European book published which is likely
to cover the same ground. However, it may well be that the
volumes are complementary rather than directly rivalling
each other.
In conclusion, this is an excellent book which plugs a gap
that needed filling. It is a must for the reference library and a
must for those rare oncologists who have a particular interest
in endocrine malignancies.
NS Reed
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The story of viruses and cancer is important for two distinct
reasons. First, some 15% or more of human cancer incidence
is linked with virus infection. Major malignancies in the
world, such as cancer of the uterine cervix, primary liver
cancer, nasopharyngeal carcinoma (NPC) and several forms
of adult T-cell leukaemias and lymphomas, have viruses as
an essential component of their aetiology and pathogenesis.
Second, oncogenic viruses opened up cancer genetics.
Oncogenes were first found in retroviruses long bef6re it was
realised that the viruses had purloined cellular genes.
Tumour-suppressor proteins were first identified through the
study of DNA viruses, as viral proteins such as E6 and E7 of
the human papillomaviruses sequester the Rb and p53 pro-
teins, which is the phenotypic equivalent of a genetic knock-
out. Thus, studies of oncogenic viruses have had a
significance far beyond that proportion of cancer actually
caused by them.
This volume on viruses and cancer represents papers given
at the 51st Symposium of the British Society for General
Microbiology. It provides a useful overview of current
research into oncogenic viruses. While some chapters are
broad reviews, others are focused more narrowly on the
authors' own research.
I particularly enjoyed David Lane's chapter on tumour-
suppressor genes and p53 and Karen Vousden's article on
cell transformation by human papillomaviruses. More than
50 pages in the volume are devoted to Epsten-Barr virus
(EBV) in relation to B-cell transformation and tumours,
whereas only two pages discuss NPC. This is in inverse ratio
to the prevalee of these tumours, and reveals the inclina-
tions of EBV specialists: lymphomas are easier to study than
carcinomas. Human adenoviruses, perhaps the most potent
oncogenc viruses of all when experimentally inoculated into
rodents, receive no mention at all, not even in George Klein's
introductory article. Perhaps they are deemed uninteresting
because they have not been associated with human cancer,
and not for want of trying. Yet this very negation is fas-
cinating and puzzling.
In the majority of well-studied viral cancers, the viral
genome plays a direct role in cell transformation and the
maintenance of the malignant phenotype. Integrated or
episomal viral genes are found in the tumour cell clones.
However, it is also becoming increasingly evident that viruses
can predispose to cancer indirectly. In this volume Ian Weller
illustrates HIV-related cancers with respect to immune
deficiency, while Jan Butel and colleagues discuss hver cancer
is relation to hepatitis B and C viruses, where chronic liver
damage may promote the emergence of the premalignant
clones of liver cells not infected by the virus.
Viral carcinogenesis may be direct or indirect, but in both
cases it can be prevented by immunisation against viral infec-
tion in the first place. Here, vaccination is discussed only in
relation to human and bovine papillomaviruses and feline
leukaemia virus. However, successful intervention studies
against hepatitis B virus are already under way in West
Africa, and time will tell if this leads to a significant drop in
the incidence of liver cancer. There appears to be a synergis-
tic relationship between virus and dietary carcinogens briefly
mentioned by Butel et al. for liver cancer and by Saveria
Campo for bovine papillomavirus type 4. A more thorough
discussion of co-factors in viral oncogenesis and the pro-
spects for prevention would not have come amiss. Nonethe-
less, for those intrested in the relation of viruses to cancer,
this volume provides a useful introduction to the field.
Professor RA Weiss
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This is the third volume in the series of reviews highlighting
growth areas in haematological oncology aimed at both
clinicians and research workers. The editors set themselves a
very difficult task in accepting such a wide remit and by and
large achieve a lot. However, such review texts become rather
piecemeal and lack the continuity of a monograph or text
committed to a specific topic. Consequently, in this volume
there is something for everyone but no topic is fully covered,
e.g. the epidemiology and viral aetiology of lymphomas are
included, but these are not put into the context of clinical
manifestation, immunophenotyping or pathology. For the
clinician reviewing a topic or for the hard-pressed examina-
tion candidate multiple texts are thus required, while the
researcher is more likely to find value in the bibliographies
and hence the original papers.
Those critical comments are applicable to all such texts
and must not detract from the well-written individual cont-
ributions, all by respected authorities in their field. Cart-
wright and McNally's Epidemiology ofNon-Hodgkin's Lym-
phomas is an excellent reference source, although so many
large tables make it difficult for the reader. I was confused by
the comment that 'no clear geographical associations
emerged' in childhood NHL and then the discussion of Bur-
kitt's lymphoma, for which there is a very characteristic
geographical variation. There were many other intriguing
items of interest which, as the authors suggest, do really
warrant further research. Onions has produced a very fine
and comprehensive overview of the viral aetiology of lym-
phoid malignancies, as has Myrtle Gordon on the stromal
microenvironment. The stroma is a complex area to study
but represents a real growing point of haematological
research, and this is a timely review of the subject. The
back-to-back chapters on myeloma therapy are especially
helpful to the practitioner deciding on therapy for an individ-
ual patient, and in particular Diana Sampson's final recom-
mendations are clear and very useful. Peripheral blood stem
cell transplantation is very much the flavour of the month,
for obvious reasons, but with the available growth factors
changing so rapidly texts such as this one inevitably become